In our study, we downloaded 109 samples from GSE91061, and the results showed that SPTSSA expression level has a positive correlation with anti-PD-1/CTLA-4 therapy both in LGG and GBM (Supplementary Figure 3A). Here, CTLA4 is linked to glioblastoma.